India In-Vitro Diagnostic Reagents Market to be dominated by Immunoassay type through 2028
Increasing funding for research activities is expected to
drive India In-Vitro Diagnostic Reagents Market in the forecast period, 2024-2028.
According to TechSci Research report, “India In-Vitro Diagnostics Reagents Market -By Region, Competition Forecast and
Opportunities, 2018-2028F”,
India In-Vitro diagnostic reagents
market is anticipated to grow at an impressive rate in the forecast period, 2024-2028.
This can be ascribed to the growing advancement in protein-engineering
technologies along with growing development in diagnostic techniques. Similarly, growing investment in the research
and development sector along with multiple collaborations with academic
institutes to maximize their gains, is further expected to increase the demand for
the In-Vitro Diagnostic Reagents market in the forecast period. Additionally,
the development of new diagnostics tests and growing awareness about new tests
with affordable costs is expected to drive the market during the forecast
period. Similarly, the growing geriatric population along with increase in
disposable income across the region is anticipated to boost the growth of the
in-vitro diagnostic reagents market during the forecast period.
However, strict
regulations and policies related to the approval of diagnostic regents can
hamper the growth of the India In-Vitro Diagnostic Reagent Market. Similarly, high
prices of the reagents along with the risk of using chemical reagents, lack of
skilled workers for using the reagents, and lack of reimbursement scenario for
IVD test are the main factors that will hamper the India In-Vitro Diagnostic Reagents Market in the forecast period.
Browse over XX market data Figures
spread through 110
Pages and an in-depth TOC on "India In-Vitro Diagnostic Reagents Market"
The India In-Vitro Diagnostic Reagents Market is segmented by type, by application, by end user and
by region.
Based on Application, the India
In-Vitro Diagnostic Reagents Market can be segmented
into Immunoassay,
Clinical Chemistry, Molecular Diagnostics, Hematology Analysers, Urinalysis, and
Others. The Immunoassay
segment is expected to dominate the market for the
forecast period because of the increasing usage of immunoassays in POC & infectious
diseases testing, and the growing development of novel tests. Similarly,
increasing number of government initiatives taken to fight chronic diseases
like influenza outbreaks, and the rising the number of cardiovascular diseases
and diabetes, are expected to propel the market growth during the forecast
period.
Based on Type, the India
In-Vitro Diagnostic Reagents Market can be further segmented
into Chemical,
Bio-Chemical, and Immunochemical.
The Immunochemical segment is predicted to dominate the market in 2023 and
maintain its dominance throughout the forecast period. However, increasing approval
of therapeutic peptides along with increasing demand for therapeutic proteins
and medicines, combined with their subsequent increase in approvals is expected
to enhance the demand for In vitro diagnostics reagents market during the
forecast period.
Major operating companies operating in India
In-Vitro Diagnostic Reagents Market
are:
- DiaSys Diagnostics
India Pvt Ltd
- Transasia
Bio-Medicals Ltd.
- Oscar Medicare Pvt.
Ltd.
- CPC Diagnostics (P)
Ltd.
- Agappe Diagnostics
Ltd
- BioSystems
Diagnostics Pvt. Ltd
- Tulip Diagnostics
(P) Ltd
PCR Biosystems has expanded its comprehensive range
of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit, a
lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive
high-throughput detection of RNA sequences. Similarly,
in 2022, the Indian government announced a complete financial cost of USD 665.5
million for the period FY 2021-22 to FY 2025-26 under the Strengthening of
Pharmaceutical Industry (SPI) Scheme. Abbott Laboratories, Sysmex
Corporation, Thermo Fisher Scientific Inc. and Biomerieux are other top four
players in the India IVD market.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“India is
expected to register the highest growth in the India In-Vitro Diagnostic Reagents
Market due to the rapid
urbanization along with growing investments by healthcare providers towards
infrastructure improvement across the region. Similarly, growing demand for
managing the burden of infectious diseases, and increasing accessibility to
healthcare services and advanced products is further expected to support the
market growth. Additionally, increasing income levels of the middle-class
population and increasing the number of hospitals, and clinics, is anticipated
to growth of the market. Similarly, growing demand for personalized medicine
for the treatment of chronic diseases along with demand for point of care
testing are expected to propel the market growth till 2028” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global management
consulting firm.
“India In-Vitro Diagnostic Reagents Market -Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028 Segmented By Type (Chemical, Bio-Chemical,
Immunochemical), By Application (Immunoassay,
Clinical Chemistry, Molecular Diagnostics, Hematology Analysers, Urinalysis,
Others), By End User (Hospitals & Clinics, Diagnostic Laboratories,
Academic & Research Institutions, Others), and By Region”, has evaluated
the future growth potential of India
In-Vitro Diagnostic Reagents Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India In-Vitro Diagnostic
Reagents Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com